PRKN and Parkinson disease: Consistent with findings of Parkin inactivation in PD brains, protein levels of multiple Parkin substrates – AIMP2, FBP1, PARIS, PDCD2, STEP61 – have been found to be elevated in patient midbrain tissue [74–76, 79, 176, 177].